LAMI FEDERICO

Lami, F., Romerio, A., Valle-Gomez, L., Martin-Camara, O., Martin-Santamaria, S., Peri, F. (2026). Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives. JOURNAL OF MEDICINAL CHEMISTRY, 69(1), 72-86 [10.1021/acs.jmedchem.5c02252]. Dettaglio

Italia, A., Franco, A., Shaik, M., Romerio, A., Lami, F., Lovisa, S., et al. (2025). Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases. In Convegno Nazionale della Divisione di Chimica dei Sistemi Biologici 2025. Trieste 18-20 Giugno 2025. Book of abstracts (pp.68-68). Dettaglio

Lami, F., Romerio, A., D'Amico, G., Peri, F. (2025). Design, synthesis and biological evaluation of a new Toll Like Receptor 4 agonist-based Antibody Drug Conjugate for cancer immunotherapy.. In Division of Chemistry of Biological Systems Italian Chemical Society Conference 2025 Book of Abstracts (pp.71-71). Dettaglio

Lami, F., Romerio, A., D'Amico, G., Peri, F. (2025). Design, synthesis and biological evaluation of a new Toll Like Receptor 4 agonist-based Antibody Drug Conjugate for cancer immunotherapy. [Altro]. Dettaglio

Lami, F., Romerio, A., D'Amico, G., Peri, F. (2025). Design, synthesis and biological evaluation of a new Toll Like Receptor 4 agonist-based Antibody Drug Conjugate for cancer immunotherapy.. Intervento presentato a: ChemBioParis, a joint ICBS / ECBS 2025 meeting October 6-9, 2025, Parigi, France. Dettaglio